Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents
碩士 === 國立中山大學 === 化學系研究所 === 98 === We designed a new series of enediyne and their derivatives, and evaluating for their growth inhibition activity against human tumor cell lines. This dissertation is composed of two parts. First, compounds 6c, 6e, 6g and 7g displayed good growth inhibition activity...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/87317551054580236019 |
id |
ndltd-TW-098NSYS5065011 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-098NSYS50650112015-10-13T18:35:39Z http://ndltd.ncl.edu.tw/handle/87317551054580236019 Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents 設計與合成具有烯雙炔結構之ombretastatinA-4衍生物為抗有絲分裂試劑 Chen-Yi Tseng 曾貞宜 碩士 國立中山大學 化學系研究所 98 We designed a new series of enediyne and their derivatives, and evaluating for their growth inhibition activity against human tumor cell lines. This dissertation is composed of two parts. First, compounds 6c, 6e, 6g and 7g displayed good growth inhibition activity against A549 (non-small-cell lung cancer), AGS (human stomach adenocarcinoma), PC-3 (prostate cancer), BT483 (breast carcinomas), HeLa (human cervical epithelioid carcinoma), OVCA (ovarian cancer cell line), SKHep (hepatocellular carcinoma), H460 (human lung cancer cell line) and SW620 (Human Colorectal Cancer Cell Line), especially compound 7g is better, and its average IC50 is 8.79μM. Second, compounds 25a and 26 displayed better growth inhibition activity against HeLa (human cervical epithelioid carcinoma), OVCA (ovarian cancer cell line), AGS (human stomach adenocarcinoma) and H460 (human lung cancer cell line), and their average IC50 are10.82 and 11.08 μM. Ming-jung Wu 吳明忠 2010 學位論文 ; thesis 182 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立中山大學 === 化學系研究所 === 98 === We designed a new series of enediyne and their derivatives, and evaluating for their growth inhibition activity against human tumor cell lines. This dissertation is composed of two parts. First, compounds 6c, 6e, 6g and 7g displayed good growth inhibition activity against A549 (non-small-cell lung cancer), AGS (human stomach adenocarcinoma), PC-3 (prostate cancer), BT483 (breast carcinomas), HeLa (human cervical epithelioid carcinoma), OVCA (ovarian cancer cell line), SKHep (hepatocellular carcinoma), H460 (human lung cancer cell line) and SW620 (Human Colorectal Cancer Cell Line), especially compound 7g is better, and its average IC50 is 8.79μM. Second, compounds 25a and 26 displayed better growth inhibition activity against HeLa (human cervical epithelioid carcinoma),
OVCA (ovarian cancer cell line), AGS (human stomach adenocarcinoma) and H460 (human lung cancer cell line), and their average IC50 are10.82 and 11.08 μM.
|
author2 |
Ming-jung Wu |
author_facet |
Ming-jung Wu Chen-Yi Tseng 曾貞宜 |
author |
Chen-Yi Tseng 曾貞宜 |
spellingShingle |
Chen-Yi Tseng 曾貞宜 Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents |
author_sort |
Chen-Yi Tseng |
title |
Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents |
title_short |
Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents |
title_full |
Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents |
title_fullStr |
Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents |
title_full_unstemmed |
Design and Synthesis of Enediyne containing Combretastatin A-4 Analogues as Antimitosis Agents |
title_sort |
design and synthesis of enediyne containing combretastatin a-4 analogues as antimitosis agents |
publishDate |
2010 |
url |
http://ndltd.ncl.edu.tw/handle/87317551054580236019 |
work_keys_str_mv |
AT chenyitseng designandsynthesisofenediynecontainingcombretastatina4analoguesasantimitosisagents AT céngzhēnyí designandsynthesisofenediynecontainingcombretastatina4analoguesasantimitosisagents AT chenyitseng shèjìyǔhéchéngjùyǒuxīshuāngguìjiégòuzhīombretastatina4yǎnshēngwùwèikàngyǒusīfēnlièshìjì AT céngzhēnyí shèjìyǔhéchéngjùyǒuxīshuāngguìjiégòuzhīombretastatina4yǎnshēngwùwèikàngyǒusīfēnlièshìjì |
_version_ |
1718035436149932032 |